[go: up one dir, main page]

US3225098A - N-substituted phenylalkylamines - Google Patents

N-substituted phenylalkylamines Download PDF

Info

Publication number
US3225098A
US3225098A US210538A US21053862A US3225098A US 3225098 A US3225098 A US 3225098A US 210538 A US210538 A US 210538A US 21053862 A US21053862 A US 21053862A US 3225098 A US3225098 A US 3225098A
Authority
US
United States
Prior art keywords
phenyl
cyclopentyl
methoxy
butylamine
pentyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US210538A
Inventor
Krohs Walter
Ther Leopold
Vogel Gerhard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of US3225098A publication Critical patent/US3225098A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/68—Preparation of compounds containing amino groups bound to a carbon skeleton from amines, by reactions not involving amino groups, e.g. reduction of unsaturated amines, aromatisation, or substitution of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Definitions

  • phenylalkylamines of the general Formula I in which R represents hydrogen, an alkyl group having from 1 to 4 carbon atoms or the benzyl group, R represents an alkyl group having from 2 to 4 carbon atoms, R represents a pentyl group or a cylclopentyl group and R and R represent an alkyl group having from 1 to 4 carbon atoms or, together with the combining carbon atom, members of a saturated carbocycle having from 5 to 6 carbon atoms, possess valuable therapeutical properties, particularly analgesic action and that said compounds may be obtained by (a) The reaction of an amine of the general Formula wherein R R have the meanings given above, with a ketone of the general Formula III (III) R. IV
  • R, and R have the meanings given above and X represents an inorganic or organic acid residue, if desired, by means of an agent splitting off the acid residue;
  • the most advantageous method of preparation of the products according to the invention is to react amines of the general Formula II with ketones of the Formula III.
  • the alkyl radicals R R and R may be. the same or different and may be straight chained or branched. There may be mentioned, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl and sec. butyl radicals.
  • amines there may be used, for example:
  • ketone of the Formula III there may be used, for example, the following compounds: acetone, methylethylketone, methylpropyl-ketone, methylbutyl-ketone, met-lb ylisopropyl-ketone, methylisobutyl-ketone, diethyl-ketone, dipropyl-ketone, methylvinyl-ketone, isopropylidene-acetone (rnesityloxide), cyclopentanone or cyclo-hexanone.
  • the amines of the Formula II to be used as starting substances are advantageously prepared by hydrogenation of the correspondingly substituted cyanides in the presence of catalysts of the 8th group of the Mendeleff Periodic System.
  • the cyanides may be prepared by reacting the correspondingly substituted benzyl-cyanides with sodium amide and alkyl or cyclopentyl halides in a solvent 1mmiscible with water.
  • the reduction of an amine of the general Formula II in the presence of a ketone of the general Formula III may, for example, be effected catalytically with the use of metals of the 8th group of the Mendeleff Periodic System, preferably with palladium catalysts.
  • the reaction may be varied in wide limits and may be adapted to special conditions. It can, for example, be carried out in the presence of an excess amount of ketone simultaneously serving as solvent.
  • the reaction is preferably effected at a temperature up to 50 C. and under a pressure of hydrogen of 50 atmospheres. When operating accordthe presence of an excess amount of ketone simultaneing to this method, the excess ketone is not hydrogenated to yield the corresponding carbinol and may be recovered.
  • nickel catalysts Raney nickel
  • the reduction may furthermore, be carried out by electrolysis.
  • the amines of the Formula II may be reacted with the esters of inorganic or organic acids of the Formula IV.
  • esters of inorganic or organic acids of the Formula IV There may be used for example, isopropyliodide, sec.butyl-bromide, 3-bromopentane, 2-bromo-3-methylbutane, 2-bromo-4-Inethyl-pentane, cyclopentyl-bromide, cyclohexyl-bromide, p-toluenesulfonic acid isoprop-yl-ester, or di-isopropyl-sulfate.
  • the reaction is preferably performed by heating the reactants in an appropriate solvent, for example, ethanol, isopropanol, benzene, toluene or xylene, at temperatures between 80 and 130 C.
  • the heating period depends on the temperature and the reactivity of the ester component and usually amounts to 1 to 20 hours.
  • the amine of the Formula II may be used in an excess of one to several times the molar quantity, and a solvent immiscible with water, in which the amine salt formed during the reaction is insoluble, may be used.
  • the acids formed there may also be used instead of the excess amine other basic compounds, for example, sodium bicarbonate, anhydrous sodium carbonate or tertiary amines, such as triethylamine or diethylaniline.
  • the reaction may also be carried out without using solvents by heating both reaction components to temperatures between 80 and 130 C., the use of the amine in a bimolar excess being advantageous.
  • Another method of preparing the compounds of the invention consists in heating amines of the Formula II with alcohols of the Formula V in the presence of Raney nickel for a prolonged period of time at temperatures between 100 C. and 120 C.
  • the heating period depends on the structure of the starting substances used and is generally between 5 and hours.
  • the substituent R represents a hydrogen atom
  • the alkoxy compounds may then be converted in the usual manner, for example by heating with hydrogen chloride, hydrogen bromide, .aluminum chloride or pyridinhydrochloride into the corresponding hydroxy compounds.
  • benzyloxy compounds are used as starting substances, for example 2-(3-benzyloxy-phenyl)-2-cyclopentyl-butylamine-(l), the reaction can be carried out in one or two stages of operation.
  • the radical R4 is introduced according to other methods, for example, by reacting an amine of the Formula II with an ester of the Formula IV, the benzyloxy group is not affected and if desiredcan be split oil in a further step of this reaction, for example, by means of noble metals of the 8th group of the Mendeleff Periodic System as catalysts.
  • the hydroxy group can be converted into the methoxy or ethoxy group by ethylation in the usual manner, for example with dimethylsulfate or diethylsulfate in an alkaline solution,
  • the products of the present invention can be converted into the corresponding acid addition salts by treatment with inorganic or organic acids.
  • inorganic acids for example a hydrohalic acid, particularly hydrochloric or hydrobromic acid, sulfuric acid, phosphoric acid, amido-sulfo acid, and organic acids such as acetic acid, propionic acid, oxalic acid, malic acid, succinic acid, lactic acid, maleic acid, furmaric acid, sorbic acid, citric acid, aceturic acid aspartic acid, p-amino-benzoic acid, salicylic acid and ethylenediamine-tetracetic acid.
  • inorganic acids for example a hydrohalic acid, particularly hydrochloric or hydrobromic acid, sulfuric acid, phosphoric acid, amido-sulfo acid
  • organic acids such as acetic acid, propionic acid, oxalic acid, malic acid, succinic acid, lactic acid, maleic acid, furmaric acid, sorbic
  • mice The analgesic activity of the new products of the invention was demonstrated in mice according to the method of Wolfi, Hardy, Goodell, J. Clin. Inv. 19, 659 (1940).
  • the preparation was administered subcutaneously or orally to a number of mice and the period of time in which the animals reacted to the thermal irritation was examined prior to and after administration of the products.
  • This method was modified in such a way that by a process of all or nothing certain criteria were used in order to ascertain the percentage of animals showing positive response in the test. Thus, relatively exact relations of the eli ective doses could be found.
  • the lowest ettective dose (dosis etfectiva minima 50) of 0.85 milligram/kilogram was ascertained for the N -sec.butyl-2- 3 '-hydroxy-phenyl -2-cyc1opentyl-butylamine-(l)-hydrochloride according to this method.
  • the lowest elfective dose of the latter substance amounts to 1.5 milligrams/kilogram on subcutaneous administration.
  • mice the lethal dose 50 for N-sec.butyl- 2-(3-hydroxy-phenyl)-2 cyclopentyl butylamine-(l)- hydrochloride is 30 milligrams/kilogram in the case of intraveneous injection, 250 milligrams/kilogram in the case of subcutaneous injection and 900 miligrams/kilogram in the case of oral administration.
  • Long-term toxicity tests showed that the compound when administered orally to dogs for 28 days in a dose of milligrams/kilogram was tolerated without causing pathologic symptoms in the clinical picture and in post mortem examinations.
  • hydrochloride revealed a marked analgesic action when administered in a dose of 2 to 4 milligrams.
  • the products of the present invention can be applied either in form of the free amines or in the form of their addition salts with physiologically tolerable acids as analgesic medicaments, if desired, in admixture with suitable solid or liquid pharmaceutical carriers such as water, vegetable oils, starch, lactose or talcum, if desired, with auxiliary agents such as stabilizing, preserving and emulsifying agents.
  • suitable solid or liquid pharmaceutical carriers such as water, vegetable oils, starch, lactose or talcum, if desired, with auxiliary agents such as stabilizing, preserving and emulsifying agents.
  • the compounds are preferably administered in the form of solutions or suspensions for injections, and of tablets, clragees, capsules and suppositories.
  • a dose of 1 to mg. may be taken into consideration and for oral administra tion a dose of 5 to 50 milligrams.
  • the 2- 3 -methoxy-phenyl -2-pentyl- 3 -butylamine- (1), boiling point 148152 C. serving as starting sub stance was obtained by hydrogenation of (3-methoxyphenyl) -ethylpentyl- 3 -acetonitrile (boiling point 148-150 C.) prepared by reacting (3-methoxy-phenyl)- ethyl-acetonitrile with sodium amide and 3-bromopentane.
  • N-isopr0pyl-2 (3-meth0xy-phenyl) -2-cycl0pentylbutylamine-(1) (a) 20 grams of 2-(3-methoxy-phenyl)-2-cyclopentylbutylamine-(1) were hydrogenated in 100 grams of acetone according to the prescriptions given in Example 1. The N-isopropyl-2-(3'-methoxy-phenyl)-2 cyclopentylbutyl-amine-(l) was obtained in a quantitative yield. Its hydrochloride melted at 145 C.
  • N -sec.butyl-2- (3 '-methoxy-phenyl -2-cycI0pentylbutylamine-(1) (a) 300 grams of 2-(3'-methoxy-phenyl)-2-cyclopentylbutylamine (1) were hydrogenated in 750 grams of methylethylketone according to the prescriptions given in Example 1.
  • the N-sec.butyl-2-(3'-methoxy-phenyl)-2- cyclopentyl-butylamine-( 1) was obtained in a quantitative yield. Its hydrochloride melted at C.
  • N-sec.butyl-2-(3'-cthoxy-phenyl)-2 cyclopentylbutylamine-(1) was obtained by causing diethylsulfate in alkaline solution to act on N-secbutyl-Z-(3'-hydroxyphenyl)-2-cyclopentyl-butylamine(1) obtained according to Example 11.
  • phenylalkylamines of the general Formula I in which R is selected from the group consisting of hydrogen, an alkyl group having from 1 to 4 carbon atoms and the benzyl group, R represents an alkyl group having from 2 to 4 carbon atoms, R is selected from the group consisting of a pentyl group and a cyclopentyl group, and R and R are selected from the group consisting of an alkyl group having from 1 to 4 carbon atoms and, together with the combining carbon atom, members of a saturated carbocycle having from 5 to 6 carbon atoms, and (2) addition salts of said compounds with physiologically compatible acids.
  • N-secbutyl-Z-(3'-hydroXy-phenyl) 2 pentyl-(3)- butylamine- 1 3.
  • N-isopropyl-Z-(3'-hydroxyphenyl) 2 cyclopentylbutylamine- 1 5.
  • N-sec.butyl-2-(3'-hydroxy-phenyl) 2 cyclopentylbutylamine- 1 6.
  • N-pentyl-(3")-2-(3-hydroxy-phenyl) 2 cyclopentyl-butylamine- 1) 7.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

United States Patent 3,225,098 N-SUBSTHTUTED PHENYLALKYLAMINES Walter Krohs, Bad Soden, Taunus, and Leopold Ther and Gerhard Vogel, Frankfurt am Main, Germany, assignors to Farbwerhe Hoeclrst Alttiengesellsehalit vormals Meister Lucius dz Briining, Frankfurt am Main, Germany, a corporation of Germany No Drawing. Filed July 17, 1962, Ser, No. 210,538 (Ilailns priority, application Germany, Italy 19, 1961, F 34,467 7 Claims. (Cl. 260-57013) The present invention relates to new phenylalkylamines which are distinguished by analgesic properties and to their method of manufacture. The present invention further provides pharmaceutical preparations having analgesic properties and containing said substances as active ingredients.
We have found that phenylalkylamines of the general Formula I in which R represents hydrogen, an alkyl group having from 1 to 4 carbon atoms or the benzyl group, R represents an alkyl group having from 2 to 4 carbon atoms, R represents a pentyl group or a cylclopentyl group and R and R represent an alkyl group having from 1 to 4 carbon atoms or, together with the combining carbon atom, members of a saturated carbocycle having from 5 to 6 carbon atoms, possess valuable therapeutical properties, particularly analgesic action and that said compounds may be obtained by (a) The reaction of an amine of the general Formula wherein R R have the meanings given above, with a ketone of the general Formula III (III) R. IV
in which R, and R have the meanings given above and X represents an inorganic or organic acid residue, if desired, by means of an agent splitting off the acid residue;
(c) Heating an amine of the general Formula II given above with an alcohol of the general Formula V 3,225,698 Patented Dec. 21, 1965 wherein R and R have the meanings given above, and, if desired, splitting oif the alkyl group in the products in which the substituent R represents an alkyl group according to known methods and, if desired, alkylating the products in which R represents hydrogen by means of an alkylating agent and, if desired reducing catalytically the products in which R represents a benzyl group in order to split off the benzyl group; and, if desired, converting the basic compounds obtained into the corresponding addition salts by means of inorganic or organic physiologically tolerable acids.
The most advantageous method of preparation of the products according to the invention is to react amines of the general Formula II with ketones of the Formula III.
The alkyl radicals R R and R may be. the same or different and may be straight chained or branched. There may be mentioned, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl and sec. butyl radicals.
As amines there may be used, for example:
2- 3 -hydroXy-phenyl) -2-pentyl- (3 -butylamine-( 1 2- (3 -hydroxy-phenyl) -2-pentyl- (3 -pentylamine-( 1 2- 3 '-hydroXy-pher1yl -2-pentyl- 3 '3 -methylbutylamine-( l 2- (3 '-hydroXy-phenyl) -2-pentyl- 3 -3 methylpentylamine-( 1),
2-(3 '-methoxy-phenyl) -2-pentyl-(3 )-butylamine-(1),
2-( 3 '-methoxy-phenyl)-2-pentyl-(3")-pentylamine-(1),
2- 3 -1nethoxy-phenyl -2-pentyl- 3 -3 -methylbutylamine-( l 2- (3 '-methoxy-phenyl -2-pentyl-( 3 -3 -methylpentylamine-( 1 2- 3 -ethoXy-phenyl -2-pentyl- 3 ")-butylamine-(1),
2- (3 -ethoxy-phenyl) -2 pentyl- 3 ")-pentylamine-(1 2- (3 -ethoxy-phenyl -2-pentyl- (3 -3 -methylbutylamine-( 1 2- 3 'eth0Xy-phenyl) -2-pentyl- (3 -3 methylpenytlamine-( l),
2- (3 '-hydroXy-phenyl)-2-cyclopentyl-butylamine-(1),
2- 3 -hydroxy-phenyl) -2-cyclopentyl-penty1amine-( l 2- (3 '-l1ydroXy-phenyl) -2cyclopentyl-3-methylbutylamine-(l),
2- (3 '-hydroXy-phenyl) -2-cyclopentyl-3-methylpentylamine- 1) 2- (3 -rnethoxy-phenyl) -2-cyclopentyl-buty1amine-( 1 2- (3 -methoxy-phenyl -2-cyclopentyl-pentylamine-( 1 2- (3 '-methoxy-phenyl -2-cyclopentyl-3 -methylbutylamine-( l 2- (3 -methoxy-phenyl -2-cyclopentyl-3-methylpentylamine-( 1),
2- (3 -ethoXy-phenyl -2-cyclopentyl-butylamine-( l 2- 3 '-ethoXy-phenyl) 2-cyclopentyl-pentylamine-( 1) 2- (3 '-ethoXy-phenyl)-2-cyclopenty1-3 -methylbutylamine-( 1 2- (3 -ethoXy-phenyl -2-cyclopentyl-3 -methylpentylamine-( 1),
2-(3 -benZyloxy-phenyl)-2-cyclopentyl-butylamine-( l),
2- 3 -benzyloXy-phenyl -2-cyclopentyl-pentylamine-( 1),
2- 3 -benzyloXy-phenyl) -2-cyclopentyl3 -methylbutylamine-( 1),
2- 3 -benzyloXy-pl1enyl -2-cyclopentyl-3 -1nethylpentylamine.
As ketone of the Formula III there may be used, for example, the following compounds: acetone, methylethylketone, methylpropyl-ketone, methylbutyl-ketone, met-lb ylisopropyl-ketone, methylisobutyl-ketone, diethyl-ketone, dipropyl-ketone, methylvinyl-ketone, isopropylidene-acetone (rnesityloxide), cyclopentanone or cyclo-hexanone.
The amines of the Formula II to be used as starting substances are advantageously prepared by hydrogenation of the correspondingly substituted cyanides in the presence of catalysts of the 8th group of the Mendeleff Periodic System. The cyanides may be prepared by reacting the correspondingly substituted benzyl-cyanides with sodium amide and alkyl or cyclopentyl halides in a solvent 1mmiscible with water.
The reduction of an amine of the general Formula II in the presence of a ketone of the general Formula III may, for example, be effected catalytically with the use of metals of the 8th group of the Mendeleff Periodic System, preferably with palladium catalysts. The reaction may be varied in wide limits and may be adapted to special conditions. It can, for example, be carried out in the presence of an excess amount of ketone simultaneously serving as solvent. The reaction is preferably effected at a temperature up to 50 C. and under a pressure of hydrogen of 50 atmospheres. When operating accordthe presence of an excess amount of ketone simultaneing to this method, the excess ketone is not hydrogenated to yield the corresponding carbinol and may be recovered. It is, however, also possible to operate without the use of the excess ketone and to use another appropriate solvent, for example, methanol. Instead of palladium, nickel catalysts (Raney nickel) may also be used. It is likewise possible to carry out the reduction with the use of nascent hydrogen, for example, by using aluminum amalgam and alcohol, sodium amalgam, lithium-aluminum hydride or sodium boron hydride. The reduction, may furthermore, be carried out by electrolysis.
According to another advantageous method of preparing the compounds of the invention, the amines of the Formula II may be reacted with the esters of inorganic or organic acids of the Formula IV. There may be used for example, isopropyliodide, sec.butyl-bromide, 3-bromopentane, 2-bromo-3-methylbutane, 2-bromo-4-Inethyl-pentane, cyclopentyl-bromide, cyclohexyl-bromide, p-toluenesulfonic acid isoprop-yl-ester, or di-isopropyl-sulfate.
The reaction is preferably performed by heating the reactants in an appropriate solvent, for example, ethanol, isopropanol, benzene, toluene or xylene, at temperatures between 80 and 130 C. The heating period depends on the temperature and the reactivity of the ester component and usually amounts to 1 to 20 hours. In order to bind the acids that have formed during the reaction the amine of the Formula II may be used in an excess of one to several times the molar quantity, and a solvent immiscible with water, in which the amine salt formed during the reaction is insoluble, may be used. For binding the acids formed there may also be used instead of the excess amine other basic compounds, for example, sodium bicarbonate, anhydrous sodium carbonate or tertiary amines, such as triethylamine or diethylaniline. The reaction may also be carried out without using solvents by heating both reaction components to temperatures between 80 and 130 C., the use of the amine in a bimolar excess being advantageous.
Another method of preparing the compounds of the invention consists in heating amines of the Formula II with alcohols of the Formula V in the presence of Raney nickel for a prolonged period of time at temperatures between 100 C. and 120 C. The heating period depends on the structure of the starting substances used and is generally between 5 and hours.
For the preparation of the products of the invention in which the substituent R represents a hydrogen atom, it is advantageous to prepare first the corresponding alkoxy or benzyloxy compound according to one of the indicated methods. The alkoxy compounds may then be converted in the usual manner, for example by heating with hydrogen chloride, hydrogen bromide, .aluminum chloride or pyridinhydrochloride into the corresponding hydroxy compounds. If benzyloxy compounds are used as starting substances, for example 2-(3-benzyloxy-phenyl)-2-cyclopentyl-butylamine-(l), the reaction can be carried out in one or two stages of operation. When introducing for example the radical R4 is introduced according to other methods, for example, by reacting an amine of the Formula II with an ester of the Formula IV, the benzyloxy group is not affected and if desiredcan be split oil in a further step of this reaction, for example, by means of noble metals of the 8th group of the Mendeleff Periodic System as catalysts.
On the other hand, if according to one of the abovedescribed methods there are obtained products in the formulae of which R represents a hydrogen atom, the hydroxy group can be converted into the methoxy or ethoxy group by ethylation in the usual manner, for example with dimethylsulfate or diethylsulfate in an alkaline solution,
The products of the present invention can be converted into the corresponding acid addition salts by treatment with inorganic or organic acids. For the salt formation the following physiologically tolerable acids may be used: inorganic acids, for example a hydrohalic acid, particularly hydrochloric or hydrobromic acid, sulfuric acid, phosphoric acid, amido-sulfo acid, and organic acids such as acetic acid, propionic acid, oxalic acid, malic acid, succinic acid, lactic acid, maleic acid, furmaric acid, sorbic acid, citric acid, aceturic acid aspartic acid, p-amino-benzoic acid, salicylic acid and ethylenediamine-tetracetic acid.
The analgesic activity of the new products of the invention was demonstrated in mice according to the method of Wolfi, Hardy, Goodell, J. Clin. Inv. 19, 659 (1940). When applying this method, the preparation was administered subcutaneously or orally to a number of mice and the period of time in which the animals reacted to the thermal irritation was examined prior to and after administration of the products. This method was modified in such a way that by a process of all or nothing certain criteria were used in order to ascertain the percentage of animals showing positive response in the test. Thus, relatively exact relations of the eli ective doses could be found. Upon subcutaneous administration the lowest ettective dose (dosis etfectiva minima 50) of 0.85 milligram/kilogram was ascertained for the N -sec.butyl-2- 3 '-hydroxy-phenyl -2-cyc1opentyl-butylamine-(l)-hydrochloride according to this method. In comparison with the known 2-dimethylamino-4,4-di phenylheptanone (5)-hydrochloride the lowest elfective dose of the latter substance amounts to 1.5 milligrams/kilogram on subcutaneous administration. Upon subcutaneous administration the present preparation thus proved to be twice as potent as the known Z-dimethylamino-4,4-diphenylheptanone (5 )-hydrochloride. When given to mice which are in a state of excitement caused by subcutaneous injection of l-phenyl-Z-methylaminopropane hydrochloride according to the method by Ther (Deutsche Apotheker-Zeitung 1953, p. 292), the abovementioned compound showed a distinctly sedative action.
Examination methods in the goldhamster (Mesocricetus auratus) according to Ther, Vogel and Werner, Arzneimittelforschung 9, 351 (1959), and examination methods in the cotton rat according to Vogel and Ther, Arzneimittelforschung 10, 806 (1960), have demonstrated sedative neuroleptic action.
Toxicity tests have revealed that the products of the present invention are to be considered harmless.
For example, in mice the lethal dose 50 for N-sec.butyl- 2-(3-hydroxy-phenyl)-2 cyclopentyl butylamine-(l)- hydrochloride is 30 milligrams/kilogram in the case of intraveneous injection, 250 milligrams/kilogram in the case of subcutaneous injection and 900 miligrams/kilogram in the case of oral administration. Long-term toxicity tests showed that the compound when administered orally to dogs for 28 days in a dose of milligrams/kilogram was tolerated without causing pathologic symptoms in the clinical picture and in post mortem examinations.
In clinical trials N-sec.butyl-2-(3-hydroxy-phenyl)-2- cyclopentyl-butylamine (1) hydrochloride revealed a marked analgesic action when administered in a dose of 2 to 4 milligrams. The products of the present invention can be applied either in form of the free amines or in the form of their addition salts with physiologically tolerable acids as analgesic medicaments, if desired, in admixture with suitable solid or liquid pharmaceutical carriers such as water, vegetable oils, starch, lactose or talcum, if desired, with auxiliary agents such as stabilizing, preserving and emulsifying agents. The compounds are preferably administered in the form of solutions or suspensions for injections, and of tablets, clragees, capsules and suppositories.
For parenteral administration a dose of 1 to mg. may be taken into consideration and for oral administra tion a dose of 5 to 50 milligrams.
The following examples serve to illustrate the invention, but they are not intended to limit it thereto:
EXAMPLE 1 N-sec.butyl-2-(3'-meth0xy-phenyl) -2-pentyl- (3)-butylamine-(1) grams of 2-(3-methoxy-pheny1)-2-penty1-(3")- butylamine-(1) and 150 grams of methylethylketone were hydrogenated at 50 C. in the presence of palladium as catalyst until the hydrogen ceased to be absorbed. After separation from the catalyst and elimination of the excess methylethylketone by distillation N-sec.butyl- 2-(3-methoxy-phenyl)-2-pentyl (3") butylamine-(1) was obtained in a quantitative yield. The corresponding fumarate melted at 107 C.
The 2- 3 -methoxy-phenyl -2-pentyl- 3 -butylamine- (1), boiling point =148152 C. serving as starting sub stance was obtained by hydrogenation of (3-methoxyphenyl) -ethylpentyl- 3 -acetonitrile (boiling point 148-150 C.) prepared by reacting (3-methoxy-phenyl)- ethyl-acetonitrile with sodium amide and 3-bromopentane.
EXAMPLE 2 By heating under reflux the N-sec.buty1-2-(3-methoxyphenyl)-2-pentyl-(3)-butylamine-( 1) with hydrobromic acid of 48% strength for 8 hours, the methyl group was split off. The N-sec.butyl-2-(3'-hydroxy-phenyl)-2-pentyl-(3")-butylamine-(1) was obtained in a quantitative yield and formed a fumarate which melted at 167 C.
EXAMPLE 3 N-isopr0pyl-2 (3-meth0xy-phenyl) -2-cycl0pentylbutylamine-(1) (a) 20 grams of 2-(3-methoxy-phenyl)-2-cyclopentylbutylamine-(1) were hydrogenated in 100 grams of acetone according to the prescriptions given in Example 1. The N-isopropyl-2-(3'-methoxy-phenyl)-2 cyclopentylbutyl-amine-(l) was obtained in a quantitative yield. Its hydrochloride melted at 145 C.
(b) The same compound was obtained by heating for 15 hours at C. 2-(3'-methoxy-phenyl)-2-cyclopentylbutylamine-(1) with excess isopropanol and a large quantity of Raney nickel.
(c) The same compound was obtained by heating for 3 hours at 100 C. 2-(3'-methoxy-phenyl)--2-cyclopentylbutylamine-(1) with one mol of diisopropyl sulfate.
EXAMPLE 4 N -sec.butyl-2- (3 '-methoxy-phenyl -2-cycI0pentylbutylamine-(1) (a) 300 grams of 2-(3'-methoxy-phenyl)-2-cyclopentylbutylamine (1) were hydrogenated in 750 grams of methylethylketone according to the prescriptions given in Example 1. The N-sec.butyl-2-(3'-methoxy-phenyl)-2- cyclopentyl-butylamine-( 1) was obtained in a quantitative yield. Its hydrochloride melted at C.
(b) The same compound was obtained by hydrogenating 2- 3 -methoxy-phenyl -2-cyclopentyl-butylarnine-( 1 with methylvinylketone and palladium as catalyst at 50 C. until the hydrogen ceased to be absorbed.
The 2-(3-methoxy-phenyl)-2-cyclopentyl butylamine- (1), boiling point =174176 C., serving as starting substance was obtained by hydrogenation of (3-methoxyphenyl) ethyl cyclopentyl acetonitrile (melting point =154-156 C.) prepared by reacting (3-methylphenyl)-ethylacetonitrile with sodium amide and cyclopentylbromide.
EXAMPLES 5-9 From 2 3 -methoxy-pher1yl -2-cyclopentyl-butylamine- (1) there were obtained the following compounds according to the process described in Example 1 by the hydrogenation with ketones:
(5 With methylisopropylketone there was obtained the N-[3"-methyl-butyl-(2")]-2-(3 methoxy phenyl) 2- cyclopentyl-butylamine-(l). Melting point of the hydrochloride: 131 C.
(6) With methylpropylketone there was obtained the N-pentyl-(2)-2-(3-methoxy-phenyl) 2 cyclopentylbutylamine-(1). Melting point of the hydrochloride 200 C.
(7) With diethylketone there was obtained the N-pentyl- (3 -2- 3 -methoxy-phenyl -2-cyclopentyl butylamine- (1). Melting point of the hydrochloride 155 C.
(8) With cyclopentanone there was obtained the N- cyclopentyl-2- 3 -methoxy-phenyl -2-cyclopentyl butylamine-(1). Melting point of the hydrochloride 230 C.
(9) With cyclohexanone there was obtained the N- cyc1ohexyl-2-(3-methoxy-phenyl)-2 cyclopentyl butylamine-(1). Melting point of the hydrochloride C.
EXAMPLES 10-17 By heating the 3-methoxy compounds described in the Examples 3 to 9 for 8 hours under reflux with hydrobromic acid of 48% strength the methyl group was split 01f, while the corresponding hydroxphenyl derivatives were formed. The following products were prepared in this manner.
10) N-isopropyl-Z- 3 -hydroxy-phenyl -2-cyclopentylbutylamine-(1); melting point of the hydrochloride: 206 C.
11a) N-sec.butyl-2-(3-hydroxy-phenyl) -2-cyclopentylbutylamine-(1); melting point of the hydrochloride: 178 C.
(111)) The same compound was obtained by hydrogenating at 50 C. the 2-(3'-hydroxy-phenyl)-2-cyclopentyl butylarnine-(l), which had been obtained by demethylation of the corresponding methoxy compound with hydrobromic acid of 48% strength and which formed a fumarate melting at 150 C., with methylethylketone and palladium as catalyst.
(12) N-[3"-methyl-butyl-(2")] 2 ('3' hydroxyphenyl)-2-cyclopentyl-butylamine-(1); melting point of the hydrochloride: 164 C.
(13) N-pentyl-(2)-2-(3-hydroxy-pheny1) 2 cyclo- 7 pentyl-butylamine-(l melting point of the hydrochloride: 212 C.
(14) N-pentyl-(3")-2-(3'-hydroxy-phenyl) 2 cyclopentyl-butylamine-( 1); melting point of the hydrochloride: 184 C.
(15) N-cyclopentyl-2-(3'-hydr0Xypheny1)-2 cyclopentyl-butylamine-( 1); melting point of the hydrochloride: 209 C.
(16) N-cyclohexyl-Z-(3-hydroXy-phenyl)-2 cyclopentyl-butylamine-(l); melting point of the hydrochloride: 236 C.
(17) N-sec.butyl-2-(3'-cthoxy-phenyl)-2 cyclopentylbutylamine-(1) was obtained by causing diethylsulfate in alkaline solution to act on N-secbutyl-Z-(3'-hydroxyphenyl)-2-cyclopentyl-butylamine(1) obtained according to Example 11.
EXAMPLE 18 N-sec.butyl-2-(3'meth0xy-phenyl) -2-cycl0pentylpentylamine-(I 16 grams of 2-(3'-methoxy-phenyl)-2-cyclopentyl-pentylamine-( 1) were hydrogenated and worked up in 150 grams of methylethylketone according to the prescription given in Example 1. The N-sec.butyl-2-(3-methoxyphenyl)-2-cyclopenty1-pentylamine-(1) was obtained in a quantitative yield. Its hydrochloride melted at 127 C. The 2-(3'-methoxy-phenyl)-2-cyclopentyl pentylamine- (1) (boiling point =178-l8O C.) serving as starting substance was obtained by hydrogenation of (3-methoxyphenyl) propyl cyclopentyl acetonitrile (boiling point =168170 C.). The latter compound can be prepared from 3-methoxybenzylcyanide, sodium amide and propyl bromide and by subsequent reaction of the (3 methoxy phenyl) propylacetonitrile (boiling pint =134135 C.) obtained with sodium amide and cyclopentylbromide.
EXAMPLE 19 N -sec.butyl-2- (3 -hydr0xy-phenyl -2-cycl0penty lpentylamine-(J By heating under reflux the N-sec.buty1-2-(3-methoxyphenyl)-2-cyclopentyl-pentylamine-( 1) with hydrobromic acid of 48% strength for 8 hours, the methyl group was split off. The N-sec.butyl-2-(3-hydroxy-phenyl)-2-cyclopentyl-pentylamine-(l) was obtained in a quantitative yield. Its hydrochloride melted at 228 C.
We claim:
1. The compounds selected from the group consisting of (1) phenylalkylamines of the general Formula I in which R is selected from the group consisting of hydrogen, an alkyl group having from 1 to 4 carbon atoms and the benzyl group, R represents an alkyl group having from 2 to 4 carbon atoms, R is selected from the group consisting of a pentyl group and a cyclopentyl group, and R and R are selected from the group consisting of an alkyl group having from 1 to 4 carbon atoms and, together with the combining carbon atom, members of a saturated carbocycle having from 5 to 6 carbon atoms, and (2) addition salts of said compounds with physiologically compatible acids.
2. N-secbutyl-Z-(3'-hydroXy-phenyl) 2 pentyl-(3)- butylamine- 1 3. N-isopropyl-2-(3'-methoXy-phenyl) 2 cyclopentylbutylamine-( 1).
4. N-isopropyl-Z-(3'-hydroxyphenyl) 2 cyclopentylbutylamine- 1 5. N-sec.butyl-2-(3'-hydroxy-phenyl) 2 cyclopentylbutylamine- 1 6. N-pentyl-(3")-2-(3-hydroxy-phenyl) 2 cyclopentyl-butylamine- 1) 7. N-sec.butyl-2-(3-hydroXy-pheny1) 2 cyclopentylbutylamine-( 1 -hydroch1oride.
References Cited by the Examiner UNITED STATES PATENTS 2,590,079 3/1952 Abell et al. 260-570.8 2,597,247 5/1952 Kerwin 260-5708 2,742,397 4/1956 Ott 16765 2,884,455 4/1959 Robertson 260-5708 3,036,954 5/1962 Robbins 16765 FOREIGN PATENTS 488,303 11/ 1952 Canada.
OTHER REFERENCES Mndzhcoyan et al.: Chemical Abstracts, volume 54, page 10910 (1960).
Weston et al.: Journal American Chemical Soc., volume 65, pages 6747 (1943).
Woods et al.: Journal Organic Chemistry, volume 19, pages 12905 (1954).
CHARLES B. PARKER, Primary Examiner. MORRIS O. WOLK, Examiner.

Claims (1)

1. THE COMPOUNDS SELECTED FROM THE GROUP CONSISTING OF (1) PHENYLALKYLAMINES OF THE GENERAL FORMULA I
US210538A 1961-07-19 1962-07-17 N-substituted phenylalkylamines Expired - Lifetime US3225098A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEF34467A DE1164399B (en) 1961-07-19 1961-07-19 Process for the preparation of new analgesic phenylalkylamines

Publications (1)

Publication Number Publication Date
US3225098A true US3225098A (en) 1965-12-21

Family

ID=7095563

Family Applications (1)

Application Number Title Priority Date Filing Date
US210538A Expired - Lifetime US3225098A (en) 1961-07-19 1962-07-17 N-substituted phenylalkylamines

Country Status (5)

Country Link
US (1) US3225098A (en)
DE (1) DE1164399B (en)
DK (2) DK106495C (en)
FR (1) FR2065M (en)
GB (1) GB1008639A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3328249A (en) * 1965-06-21 1967-06-27 Sterling Drug Inc Process for counteracting depressive states
US3946119A (en) * 1974-12-23 1976-03-23 Sandoz, Inc. Optionally substituted α-tertiary butyl-p-phenoxybenzylamines and their use as hypolipidemic agents
US4975345A (en) * 1990-02-21 1990-12-04 Lilliwyte Societe Anonyme Electrochemical cell
US5300691A (en) * 1993-05-28 1994-04-05 Hoechst Celanese Corporation Substituted benzyl amines
US5312990A (en) * 1993-05-28 1994-05-17 Hoechst Celanese Corporation Di-amino compounds

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2590079A (en) * 1947-09-23 1952-03-25 Wyeth Corp Tertiary butyl amines and their preparation
US2597247A (en) * 1948-08-02 1952-05-20 Smith Kline French Lab Nu-substituted amino-ethanols
CA488303A (en) * 1952-11-18 Fausset Bruce William Tertiary butyl secondary amines and method for preparing the same
US2742397A (en) * 1953-06-09 1956-04-17 Commercial Solvents Corp Analgetic compositions of n-(1-methyl propyl) cyclohexylamine
US2884455A (en) * 1956-10-29 1959-04-28 Dow Chemical Co Propynyl phenylethylamines and their halogen acid salts
US3036954A (en) * 1959-10-05 1962-05-29 Lilly Co Eli Analgesic compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1095840B (en) * 1955-07-01 1960-12-29 Thomae Gmbh Dr K Process for the preparation of tertiary amines
DE1058063B (en) * 1957-02-08 1959-05-27 Hoechst Ag Process for the preparation of substituted phenylethylamines with analgesic activity

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA488303A (en) * 1952-11-18 Fausset Bruce William Tertiary butyl secondary amines and method for preparing the same
US2590079A (en) * 1947-09-23 1952-03-25 Wyeth Corp Tertiary butyl amines and their preparation
US2597247A (en) * 1948-08-02 1952-05-20 Smith Kline French Lab Nu-substituted amino-ethanols
US2742397A (en) * 1953-06-09 1956-04-17 Commercial Solvents Corp Analgetic compositions of n-(1-methyl propyl) cyclohexylamine
US2884455A (en) * 1956-10-29 1959-04-28 Dow Chemical Co Propynyl phenylethylamines and their halogen acid salts
US3036954A (en) * 1959-10-05 1962-05-29 Lilly Co Eli Analgesic compositions

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3328249A (en) * 1965-06-21 1967-06-27 Sterling Drug Inc Process for counteracting depressive states
US3946119A (en) * 1974-12-23 1976-03-23 Sandoz, Inc. Optionally substituted α-tertiary butyl-p-phenoxybenzylamines and their use as hypolipidemic agents
US4975345A (en) * 1990-02-21 1990-12-04 Lilliwyte Societe Anonyme Electrochemical cell
US5300691A (en) * 1993-05-28 1994-04-05 Hoechst Celanese Corporation Substituted benzyl amines
US5312990A (en) * 1993-05-28 1994-05-17 Hoechst Celanese Corporation Di-amino compounds

Also Published As

Publication number Publication date
DK106495C (en) 1967-02-13
GB1008639A (en) 1965-11-03
DK108978C (en) 1968-03-04
DE1164399B (en) 1964-03-05
FR2065M (en) 1963-10-07

Similar Documents

Publication Publication Date Title
US3422196A (en) Utilizing 1 - (3,5 - dihydroxyphenyl)-1-hydroxy - 2 - isopropylaminoethane and salts thereof in the treatment of bronchial spasms
US3117160A (en) Aralkylamines
BG60761B2 (en) Aryloxyphenyl propylamines
HU180156B (en) Process for preparing substituted piperidine derivatives
HU207280B (en) Process for producing new phenyl-alkyl-amines and pharmaceutical compositions containing them
DE1668055B2 (en) BASIC SUBSTITUTED CYCLOPENTYLPHENOLETHERS, THEIR SALT WITH PHYSIOLOGICALLY COMPATIBLE ACIDS AND PROCESS FOR THEIR PRODUCTION
DE1963182C2 (en) 3- (3-Methylaminopropyl) -1-phenylindoline, process for its preparation and its use in combating depressive states
US3558652A (en) N-monosubstituted pyrrylaminoethanols
US4029731A (en) Aminophenyltetralin compounds
US3225098A (en) N-substituted phenylalkylamines
DE2420618A1 (en) AMINO ALKYLANILIDE
US3202711A (en) Nu-substituted phenalkyl amines
EP0076669A1 (en) Novel 3-phenyl-1-indanamines, pharmaceutical compositions and methods of preparation
US3514486A (en) 3-isopropylnorbornanamine
EP0063084A1 (en) Phenethanol amine derivatives, their preparation and use in medicine
DE2409313C2 (en) 1- [2-Pyrrolyl- (1) -phenoxy] -2-hydroxy-3-aminopropane derivatives, processes for their production and pharmaceutical preparations
US3096244A (en) Substituted butyric acid amide and analgesia
US3188349A (en) N-secondary-alkyl-2-(3-hydroxyphenyl)-2-ethyl-alkylamines
US2504122A (en) Nu-allyl-1, 2-diphenylethylamine
US3334017A (en) Phenylalkylhydrazine compositions
DE2061864A1 (en)
US2361524A (en) beta-alkyl-substituted ethylamines
DE1493961C3 (en) l-Hydroxy-2-alkylamino-l-phenyläthanderivate their acid addition salts, process for their production and pharmaceutical preparations
US3457354A (en) Treatment of hypertension with 2-hydroxy (or amino) - 4,5 - dihydroxyphenethylamine derivatives
US3377359A (en) Amino derivatives, comprising heterocycles, their salts, and process for preparation